Stockscreener 앱 받기
34.99
4.11%
-1.50
Vtv Therapeutics Inc 주식(VTVT)의 최신 뉴스
vTv Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Type 1 diabetes drug developer vTv set for two investor conferences - Stock Titan
Is vTv Therapeutics Inc.’s ROE strong enoughQuarterly Growth Report & Smart Allocation Stock Reports - mfd.ru
Aug Retail: Does vTv Therapeutics Inc have strong fundamentalsEarnings Overview Report & Stepwise Swing Trade Plans - baoquankhu1.vn
(VTVT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Q1 EPS Forecast for vTv Therapeutics Increased by Analyst - Defense World
HC Wainwright Boosts Earnings Estimates for vTv Therapeutics - MarketBeat
Will vTv Therapeutics Inc outperform the market in YEARQuarterly Trade Report & Stepwise Trade Signal Guides - baoquankhu1.vn
Analysts Are Bullish on These Healthcare Stocks: vTv Therapeutics (VTVT), Acumen Pharmaceuticals (ABOS) - The Globe and Mail
vTv Therapeutics expands HPP737 license agreement with Newsoara Biopharma By Investing.com - Investing.com India
vTv Therapeutics expands HPP737 license agreement with Newsoara Biopharma - Investing.com
vTv Therapeutics Expands Global HPP737 Rights with Newsoara - TipRanks
vTv Therapeutics Signs License Agreement Amendment With Newsoara Biopharma - TradingView
vTv expands Newsoara license deal for PDE4 inhibitor to global rights - Investing.com India
VTVT Expands Global Rights Agreement for PDE4 Inhibitor - GuruFocus
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737 - GlobeNewswire
Analysts Set vTv Therapeutics Inc. (NASDAQ:VTVT) Price Target at $55.25 - Defense World
VIX Spike: Is vTv Therapeutics Inc likely to announce a buybackMarket Volume Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
vTv Therapeutics Inc. (NASDAQ:VTVT) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Published on: 2026-01-29 06:19:41 - baoquankhu1.vn
VTVT: BTIG Raises Price Target to $49.00, Maintains Buy Rating | - GuruFocus
How (VTVT) Movements Inform Risk Allocation Models - Stock Traders Daily
vTv Therapeutics (NASDAQ:VTVT) Upgraded to Strong-Buy at Roth Mkm - MarketBeat
This MasTec Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Roth Capital Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq
Roth/MKM initiates coverage on vTv Therapeutics stock with Buy rating - Investing.com Canada
Roth Capital Initiates Coverage on VTVT with a 'Buy' Rating | VT - GuruFocus
Buyout Rumor: Does vTv Therapeutics Inc have declining or rising EPSWeekly Gains Summary & Verified Momentum Stock Alerts - baoquankhu1.vn
Published on: 2026-01-19 16:04:02 - baoquankhu1.vn
vTv Therapeutics (VTVT) upgraded to buy: Here's what you should know - MSN
Meme Stocks: Should I hold or sell Aethlon Medical Inc nowJuly 2025 News Drivers & Technical Buy Zone Confirmation - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Stop Loss: Can IRDM navigate macro headwindsWeekly Market Outlook & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Short Interest in vTv Therapeutics Inc. (NASDAQ:VTVT) Rises By 62.3% - MarketBeat
Trading Systems Reacting to (VTVT) Volatility - Stock Traders Daily
vTv Therapeutics (VTVT) Price Target Increased by 16.19% to 48.20 - Nasdaq
Alzheimer’s Disease Market in the 7MM is projected to reach USD 34 Billion by 2034, analyses DelveInsight - The Globe and Mail
Market Pulse: What margin trends mean for vTv Therapeutics Inc stockJuly 2025 Earnings & Fast Entry Momentum Trade Alerts - Bộ Nội Vụ
Analysis Recap: Will vTv Therapeutics Inc face regulatory challengesWeekly Trade Report & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
How vTv Therapeutics Inc. stock reacts to global recession fearsTrade Ideas & Community Shared Stock Ideas - Улправда
Smart Money: Can vTv Therapeutics Inc. (5VT0) stock attract analyst upgrades2025 Growth vs Value & Target Return Focused Stock Picks - ulpravda.ru
How vTv Therapeutics Inc. (5VT0) stock reacts to new regulationsRate Hike & Free Accurate Trade Setup Notifications - Улправда
Why institutional investors increase stakes in vTv Therapeutics Inc. (5VT0) stockWeekly Risk Summary & Daily Technical Stock Forecast Reports - Улправда
P 500 performance this yearJuly 2025 Levels & Real-Time Market Trend Scan - Улправда
Momentum Shift: How vTv Therapeutics Inc. (5VT0) stock reacts to new regulations2025 AllTime Highs & Daily Stock Trend Reports - Улправда
Should I hold or sell vTv Therapeutics Inc. stock in 2025July 2025 Final Week & Growth Focused Stock Pick Reports - Улправда
Brokerages Set vTv Therapeutics Inc. (NASDAQ:VTVT) PT at $51.33 - Defense World
Is vTv Therapeutics Inc. stock supported by innovation pipeline2026 world cup usa national team group stage goalkeepers build up play knockout prediction statistical analysis - Улправда
vTv Therapeutics (NASDAQ:VTVT) Now Covered by Analysts at TD Cowen - Defense World
TD Cowen Initiates Coverage of vTv Therapeutics (VTVT) with Buy Recommendation - Nasdaq
An Alzheimer’s Drug Could Supercharge This High-Risk Stock. Is It Worth a Buy Here? - Yahoo Finance
vTv Therapeutics Inc. (NASDAQ:VTVT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
VTVT: TD Cowen Initiates Coverage with a Buy Rating and $67 Pric - GuruFocus
This vTv Therapeutics Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
vTv Therapeutics stock initiated with Buy rating at TD Cowen By Investing.com - Investing.com Canada
1.00%
1.18%
자본화:
|
볼륨(24시간):